158 related articles for article (PubMed ID: 17967516)
1. Fractionated grid therapy in treating cervical cancers: conventional fractionation or hypofractionation?
Zhang H; Wang JZ; Mayr N; Kong X; Yuan J; Gupta N; Lo S; Grecula J; Montebello J; Martin D; Yuh W
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):280-8. PubMed ID: 17967516
[TBL] [Abstract][Full Text] [Related]
2. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
Zhang H; Zhong H; Barth RF; Cao M; Das IJ
Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric validation of the MCNPX Monte Carlo simulation for radiobiologic studies of megavoltage grid radiotherapy.
Zhang H; Johnson EL; Zwicker RD
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1576-83. PubMed ID: 17126214
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic advantage of grid irradiation for large single fractions.
Zwicker RD; Meigooni A; Mohiuddin M
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1309-15. PubMed ID: 15001276
[TBL] [Abstract][Full Text] [Related]
5. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
6. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.
Gay HA; Sibata CH; Allison RR; Jeremic B
Radiother Oncol; 2009 Jun; 91(3):369-78. PubMed ID: 19058867
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.
Yuan J; Wang JZ; Lo S; Grecula JC; Ammirati M; Montebello JF; Zhang H; Gupta N; Yuh WT; Mayr NA
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):390-7. PubMed ID: 18374501
[TBL] [Abstract][Full Text] [Related]
8. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
9. Linear quadratic model compared with TDF and TSD concepts for malignancy of cervix uteri treated with twice daily fractionated schedules.
Chougule A
Strahlenther Onkol; 1994 Jan; 170(1):30-5. PubMed ID: 8303575
[TBL] [Abstract][Full Text] [Related]
10. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
Strigari L; Arcangeli G; Arcangeli S; Benassi M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
[TBL] [Abstract][Full Text] [Related]
11. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
12. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
13. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
Cui M; Gao XS; Li X; Ma M; Qi X; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):54. PubMed ID: 35303922
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients.
Bhosle SM; Huilgol NG; Mishra KP
Cancer Detect Prev; 2005; 29(4):369-75. PubMed ID: 16125335
[TBL] [Abstract][Full Text] [Related]
15. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
Gay HA; Jin JY; Chang AJ; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
[TBL] [Abstract][Full Text] [Related]
16. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1538-43. PubMed ID: 18786779
[TBL] [Abstract][Full Text] [Related]
17. Is α/β for breast cancer really low?
Qi XS; White J; Li XA
Radiother Oncol; 2011 Aug; 100(2):282-8. PubMed ID: 21367477
[TBL] [Abstract][Full Text] [Related]
18. Is grid therapy useful for all tumors and every grid block design?
Gholami S; Nedaie HA; Longo F; Ay MR; Wright S; Meigooni AS
J Appl Clin Med Phys; 2016 Mar; 17(2):206-219. PubMed ID: 27074484
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiation therapy in the modern era.
Graham MV
Rays; 1999; 24(3):400-5. PubMed ID: 10605300
[TBL] [Abstract][Full Text] [Related]
20. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
